A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

被引：0
|
作者：
Cremers, SCLM
den Hartigh, J
Hamdy, NAT
Vermeij, P
Papapoulos, SE
机构：
[1] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RA Leiden, Netherlands
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B43
引用
收藏
页码：48S / 48S
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF INTRAVENOUS PROCAINAMIDE IN NORMALS
    BOUDOULAS, H
    COYLE, JD
    LIMA, JJ
    MACKICHAN, JJ
    LEWIS, RP
    CLINICAL RESEARCH, 1984, 32 (04): : A777 - A777
  • [42] Pharmacodynamic and pharmacokinetic characteristics of intravenous drugs in status epilepticus
    Bialer, Meir
    EPILEPSIA, 2009, 50 : 44 - 48
  • [43] DEVELOPMENT OF A MODEL FOR INTEGRATED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF INTRAVENOUS ANESTHETIC AGENTS - APPLICATION TO MINAXOLONE
    MATHER, LE
    SEOW, LT
    ROBERTS, JG
    GOURLAY, GK
    COUSINS, MJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (05) : 371 - 381
  • [44] Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers
    Hamitouche, Noureddine
    Comets, Emmanuelle
    Ribot, Megane
    Alvarez, Jean-Claude
    Bellissant, Eric
    Laviolle, Bruno
    AAPS JOURNAL, 2017, 19 (03): : 727 - 735
  • [45] Assessment of the pharmacokinetic and pharmacodynamic effects of intravenous clopidogrel in humans
    Cushing, Daniel
    Lipicky, Raymond
    Kowey, Peter
    Cannon, Christopher
    Adams, Michael
    Cooper, Warren
    Mosher, Gerold
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A70 - A70
  • [46] Pharmacokinetic and Pharmacodynamic Concepts Underpinning Total Intravenous Anesthesia
    Schnider, Thomas W.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 : S7 - S10
  • [47] Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
    M. A. Krieg
    C. Seydoux
    L. Sandini
    J. J. Goy
    D. Gillard Berguer
    D. Thie´baud
    P. Burckhardt
    Osteoporosis International, 2001, 12 : 112 - 116
  • [48] Cyclical intravenous pamidronate in the treatment of severe osteoporosis for upto 6 years
    Bennett, AN
    Smith, GR
    Spector, T
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 447 - 447
  • [49] The effect of intravenous pamidronate on bone mineral density in patients with refractory osteoporosis
    Cohen, H.
    Rhys-Dillon, C. C. G.
    Laji, K.
    Martin, J. C.
    Morgan, J.
    Rajan, K. T.
    RHEUMATOLOGY, 2001, 40 : 96 - 96
  • [50] Intravenous pamidronate therapy for treatment of osteoporosis. What is the optimum dose?
    Wimalawansa, SJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S173 - S173
12345